Da Vinci is
challenging lap
as the primary
surgical modality
MAT03105 US v1 01/2024
Important safety information
For intended use and/or indications for use, risks, cautions, and warnings and full prescribing
information, refer to the associated user manual(s) or visit manuals.intuitivesurgical.com/market.
© 2024 Intuitive Surgical Operations, Inc. All rights reserved. Product and brand names/logos are
trademarks or registered trademarks of Intuitive Surgical or their respective owner.
Intuitive's Privacy Notice is available at intuitive.com/privacy
*Procedures included: bariatrics, cholecystectomy, colorectal, foregut, inguinal hernia, ventral hernia,
hysterectomy - benign & radical, lung resection, nephrectomy - partial & radical, and prostatectomy
procedures. Estimates based on Open and Lap data from IQVIA, and Intuitive internal data for robotic
procedure volumes. Data on ‹ le at Intuitive. 2022 and 2023 uses 2021 IQVIA projected volumes for lap
and open. 2022 dV volumes are actuals via onsite connected systems. 2023 dV volumes is based on full
year estimates from latest Intuitive forecast in September 2023.
29% 13%
growth in da Vinci
®
surgical
procedures performed in the
U.S. from 2012 to 2023
*
decline in laparoscopic
procedures performed in the
U.S. from 2012 to 2023
*
Is your minimally invasive service line equipped
to meet the growing demand for da Vinci
®
robotic-assisted surgery?
Learn more at intuitive.com
Proud supporter of
